NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Fusix Biotech

Fusix Biotech

Private
MunichHealthcare & Life Scienceshttps://fusixbiotech.de/

Last Round

Grant

Dec 13, 2023

Total Funding Raised

$1.73M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Fusix Biotech is a biotechnology company that is a developer of a cancer therapy designed for commercializing a novel fusion-based oncolytic viro-immunotherapy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

oncolytic virus platformcancer immunotherapyimmuno-oncologysolid tumor therapyviral vector therapycancer-killing virusfusogenic cell deathpreclinical biotechgene therapybiologics developmenthepatocellular carcinomabiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fusix Biotech Comps

Public and private peers based on sector, stage, and business model.

Fusix Biotech comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Fusix Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 13, 2023
GrantSep 27, 2023
Pre SeedJul 1, 2022

Fusix Biotech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    Monthly visitors increased 145% MoM.

  • Jun 1, 2025

    Monthly visitors grew 427% MoM, from 48 to 253.

Fusix Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fusix Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fusix Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersMunich
Employee Range3
Year Founded2022
Last FundingDec 13, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.